However, SMARD1 — just like SMA and ALS — is not exclusively a motor neuron disease; therefore, IGHMBP2 deficits in other tissues not reached by scAAV9-Abt1 delivery remain impacted. The gene discussed is SMN1; the disease is motor neuron disorder.